FDA Turns Kratom's Future In US Dietary Supplement Market Into History

FDA Commissioner Scott Gottlieb says kratom's apparently increasing use "as an alternative or adjunct to opioid use" has made enforcement on the ingredient more of a priority for FDA, and "given the scope of this crisis, we must do more."

Questions on how long kratom, a botanical used in some dietary supplements, has been available in the US are rendered moot with FDA moving to stop all sales of the ingredient due to growing concerns about its safety and claims that it treats narcotic addictions.

More from Ingredients & Safety

More from HBW Insight